Short Interest in NewGenIvf Group Limited (NASDAQ:NIVF) Rises By 311.9%

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 64,064 shares, an increase of 311.9% from the April 30th total of 15,554 shares. Based on an average daily volume of 2,648,206 shares, the short-interest ratio is presently 0.0 days. Currently, 38.1% of the shares of the company are sold short.

NewGenIvf Group Stock Performance

NewGenIvf Group stock opened at $1.03 on Friday. The firm’s 50 day simple moving average is $1.66 and its 200 day simple moving average is $6.74. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a 1-year low of $0.72 and a 1-year high of $1,839.00.

NewGenIvf Group (NASDAQ:NIVF) last posted its earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share for the quarter. The company had revenue of $1.42 million for the quarter. Analysts expect that NewGenIvf Group will post 4.74 earnings per share for the current fiscal year.

Insider Activity

In other news, major shareholder Financial Lp Hrt sold 85,317 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $0.80, for a total value of $68,253.60. Following the sale, the insider owned 54,561 shares of the company’s stock, valued at $43,648.80. The trade was a 60.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 31.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.